Haemonetics Corporation (NYSE:HAE) Q3 2021 Results Earnings Conference Call February 2, 2021 8:00 AM ET Company Participants Olga Guyette - Director, Investor Relations Christopher Simon - President and Chief Executive Officer Stewart Strong - President, Global Hospital William Burke - Executive Vice President and Chief Financial Officer Conference Call Participants David Lewis - Morgan Stanley Larry Keusch - Raymond James Anthony Petrone - Jefferies David Turkaly - JMP Securities Mike Matson - Needham & Co ...

Haemonetics' Acquisition of Cardiva Medical February 2, 2021 HAEMONETICS® © 2021 Haemonetics Corporation Forward-Looking Statements and Non-GAAP Financial Measures FORWARD LOOKING STATEMENTS Any statements contained in this presentation that do not describe historical facts may constitute forward-looking statements. Forward-looking statements in this presentation may include, without limitation, plans and objectives of management for the operation of Haemonetics Corporation (the "Company"), statements regar ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 26, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of incorporation or organizat ...

Haemonetics Corporation (NYSE:HAE) Q2 2021 Earnings Conference Call November 4, 2020 8:00 AM ET Company Participants Olga Guyette - Director of IR Chris Simon - CEO, President & Director Bill Burke - CFO & Executive VP Conference Call Participants Anthony Petrone - Jefferies Larry Keusch - Raymond James David Lewis - Morgan Stanley Dave Turkaly - JMP Securities Mike Matson - Needham & Company Mike Petusky - Barrington Research Operator Ladies and gentlemen, thank you for standing by, and welcome to the Haem ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of incorporation or organization) 125 Summer Street Boston, Massachusetts 02110 (Address of principal executive offices) (Zip Code) (781) 848-7100 For the quarterly period ended: September 26, 2020 OR ☐ TRAN ...

Haemonetics Corporation (NYSE:HAE) Q1 2020 Earnings Conference Call August 4, 2020 8:00 AM ET Company Participants Dan Goldstein - Vice President, Corporate Controller Chris Simon - Chief Executive Officer Chad Nikel - President, Blood Center Bill Burke - Chief Financial Officer Conference Call Participants David Lewis - Morgan Stanley Anthony Petrone - Jefferies Larry Keusch - Raymond James Larry Solow - CJS Securities David Saxon - Needham & Company Dave Turkaly - JMP Securities Anthony Petrone - Jefferie ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 27, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of incorporation or organization) ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 28, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Boston, Massachusetts (Zip Code) (Address of principal executive ...

Haemonetics Corporation (NYSE:HAE) Q4 2020 Earnings Conference Call May 5, 2020 8:00 AM ET Company Participants Olga Guyette – Director-Investor Relations Chris Simon – Chief Executive Officer Bill Burke – Chief Financial Officer Conference Call Participants David Lewis – Morgan Stanley Larry Keusch – Raymond James Anthony Petrone – Jefferies Dave Turkaly – JMP Larry Solow – CJS Securities Mike Matson – Needham & Company Operator Good day, ladies and gentlemen, and welcome to the Haemonetics Fourth Quarter ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 28, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts 04-2882273 (State or other jurisdiction of incorporation or organizat ...